CAPR News

CAPR Shareholders Have Opportunity to Lead Capricor Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Before September 28, 2026 - Contact Levi & Korsinsky

Kaplan Fox Advises Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of an Upcoming Securities Class Action Deadline on September 28, 2026

Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 28, 2026 Deadline

Pomerantz LLP Reminds Shareholders with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit – CAPR

CAPR Securities Losses: Capricor Therapeutics Investors with Losses on their Investment are Reminded to Contact BFA Law by September 28 Deadline in Securities Fraud Class Action

Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 28, 2026 Deadline

Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline

Class Action Lawsuit Filed: Capricor Therapeutics, Inc. (CAPR) - Join by September 28, 2026 - Contact Levi & Korsinsky

Kaplan Fox Reminds Investors: Capricor Therapeutics, Inc. (CAPR) Securities Class Action Deadline is September 28, 2026 Ready to Announce with Confidence?